Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07010978 · ClinicalTrials.gov registry record · NA

Towards Testing the Effectiveness of Recovery Community Centers (RCCs)

A NA study of Opioid Use Disorder, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT07010978: Recruiting NA study of Opioid Use Disorder, sponsored by Massachusetts General Hospital.

NCT07010978 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 128 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07010978, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot randomized clinical trial is to prepare for a larger randomized clinical trial (RCT) and collect some early data to learn if the intervention can help people who use medications for opioid use disorder (MOUD). The main questions it aims to answer are: 1. Is it feasible to recruit and randomize people to both treatment groups? 2. Does linking people to recovery community centers lead to better recovery outcomes? Researchers will compare linking people to recovery community centers (RCC) to enhanced treatment as usual to see if recovery outcomes are different. In one group, participants will learn about their local RCC and will be asked to visit their local RCC on at least two days and write about their experiences. In the other group, participants will learn about different recovery activities, pick any two, and do the activities of their choice on at least two days. They will also be asked to write about their experiences. People in both groups will answer online survey questions about their recovery outcomes and well-being in five surveys over one year.

Primary Outcome

The recruitment rate will be estimated from the number of study participants enrolled per month; this information will be used for planning a subsequent R01, in line with the goals of the R34 mechanism used to fund this study. The recruitment rate will be reported as mean with standard deviation (based on monthly observations) and will be reported descriptively.

Conditions Studied

Interventions

  • BEHAVIORAL Recovery Community Center Participation
  • BEHAVIORAL Enhance Treatment as Usual

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2025-08-20
Est. Completion 2027-04-15
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT07010978 shows while recruiting

NCT07010978 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Recovery Community Center Participation is the first listed.

NCT07010978 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07010978 about?

NCT07010978 is a clinical study titled "Towards Testing the Effectiveness of Recovery Community Centers (RCCs)". The goal of this pilot randomized clinical trial is to prepare for a larger randomized clinical trial (RCT) and collect some early data to learn if the intervention can help people who use medications for opioid use disorder (MOUD). The main questions it aims to answer are: 1. Is it feasible to rec...

What is the current status of trial NCT07010978?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-08-20. Estimated completion is 2027-04-15.

What conditions does trial NCT07010978 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT07010978?

The interventions under investigation include: Recovery Community Center Participation (BEHAVIORAL), Enhance Treatment as Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT07010978?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07010978 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07010978's enrollment target sits among peer trials

128 117th of 257 higher than 140 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07010978, the US trial registry maintained by the National Library of Medicine. NCT07010978 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.